Cargando…
Cuproptosis-related gene expression is associated with immune infiltration and CD47/CD24 expression in glioblastoma, and a risk score based on these genes can predict the survival and prognosis of patients
INTRODUCTION: Glioblastoma (GBM) is the most invasive type of glioma, is insensitive to radiotherapy and chemotherapy, and has high proliferation and invasive ability, with a 5-year survival rate of <5%. Cuproptosis-related genes (CRGs) have been successfully used to predict the prognosis of many...
Autores principales: | Li, Erliang, Qiao, Huanhuan, Sun, Jin, Ma, Qiong, Lin, Li, He, Yixiang, Li, Shuang, Mao, Xinggang, Zhang, Xiaoping, Liao, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399623/ https://www.ncbi.nlm.nih.gov/pubmed/37546426 http://dx.doi.org/10.3389/fonc.2023.1011476 |
Ejemplares similares
-
Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021) -
Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
por: Yang, Mei, et al.
Publicado: (2022) -
Significance of CD47 expression in gastric cancer
por: Sudo, Tomoya, et al.
Publicado: (2017) -
Regulation of CD47 expression in cancer cells
por: Huang, Can-Yu, et al.
Publicado: (2020) -
Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
por: Chen, Jiejian, et al.
Publicado: (2022)